Kattakuzhy, MD, joins The UMB Pulse this month to talk about her research exploring whether semaglutide (a GLP-1 medication widely used for diabetes and weight management) could help reduce cravings and improve outcomes for people with stimulant use disorder
The first alcohol drinking experiment explores the effect of semaglutide (0.026 mg/kg, sc) combined with varenicline (1.5 mg/kg, sc) on alcohol consumption
"Ondansetron (Zofran) can be effective during the first 12 days," she says
Many people choose a time when they can rest if mild nausea occurs, typically choosing evenings at home rather than before a busy workday
A 2025 JAMA Internal Medicine trial compared oral versus extended-release injectable naltrexone in 248 hospitalized patients with alcohol use disorder
The risk calculus will differ depending on whether a patient is using these drugs for diabetes, obesity or just general weight loss